No Carolina / NY / Florida
Ph: 561.316.3330

HomeFDA

Category: FDA

XT-Thrive® Drug Master File (DMF)...

X-Therma notes this DMF covers the Chemistry, Manufacturing and Controls (CMC) for this key chemistry innovation, which enables non-toxic cryopreservation for life-saving regenerative medicines.

Simpson Interventions Receives FDA Breakthrough...

Simpson Interventions is committed to collaborating closely with the FDA and other stakeholders to advance the development and regulatory review of the Acolyte Image Guided Crossing and Re-Entry Catheter System. The company looks forward to bringing this revolutionary technology to clinicians, and patients in need.

XT-Thrive® Drug Master File (DMF) Accepted by the FDA | Reports X-Therma

X-Therma notes this DMF covers the Chemistry, Manufacturing and Controls (CMC) for this key chemistry innovation, which enables non-toxic cryopreservation for life-saving regenerative medicines.

FDA Grants Vapotherm Oxygen Assist Module (OAM™) Breakthrough Device Designation

Vapotherm Oxygen Assist Module is a module for use with most versions of Vapotherm’s Precision Flow® systems.

OrthoSensor Receives 510(k) Alignment Clearance For VERASENSE™

OrthoSensor notes VERASENSE™ is to be used with Zimmer Biomet's Persona Knee System.

MBio is Seeking FDA Approval for LightDeck® Platform

MBio has been working with DARPA on a program, "Point-of-care Monitoring of the Host-Pathogen Interaction During Infection," since February 2018.

iTind Device Receives FDA de Novo Classification Order for Benign Prostatic Hyperplasia: A Non-Surgical Treatment Device

The iTind device was developed by the Israeli-based medical device manufacturer Medi-Tate.

US based NEXVOO Announces the Availability of Additional FDA and CE PPE

NEXVOO announced that it is assisting with the US and global pandemic by expanding its resources to offer additional PPE products into the US.

FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19

The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19. As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood.

BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.A.

The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test that will enable hospitals to screen for COVID-19 (coronavirus) on site and get results in under three hours.

FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic

As part of the FDA's ongoing commitment to fight the Coronavirus Disease 2019 pandemic, today the agency issued guidance for immediate implementation to address the urgent and immediate need for blood and blood components. 

By using this website you agree to accept Medical Device News Magazine Privacy Policy